| Code | CSB-YP011671HU1 |
| Abbreviation | Recombinant Human CXCL8 protein, partial (Active) |
| MSDS | |
| Size | $250 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
CXCL8 orchestrates neutrophil recruitment and activation at sites of inflammation, making precise control of its signaling potency essential for dissecting immune cell behavior in vitro. This recombinant protein, spanning residues 28–99 of the mature human sequence, demonstrates specific antibody binding in functional ELISA with an EC50 of 43.95–46.76 ng/mL, providing quantitative evidence of correct folding and epitope accessibility that supports its use as a coating antigen in antibody validation assays, an immunogen for monoclonal antibody development, and a positive control in cytokine detection platforms. The endotoxin level below 1.0 EU/μg meets the threshold required for neutrophil chemotaxis assays and primary immune cell activation studies, where LPS contamination would confound interpretation of CXCL8-specific signaling through CXCR1 and CXCR2. Purity exceeding 95% by SDS-PAGE, combined with the validated binding activity, aligns with standards expected in signaling pathway studies examining NF-κB and MAPK activation downstream of chemokine receptor engagement.
There are currently no reviews for this product.